American Portfolios Advisors Catalyst Biosciences, Inc. Transaction History
American Portfolios Advisors
- $2.36 Trillion
- Q3 2022
A detailed history of American Portfolios Advisors transactions in Catalyst Biosciences, Inc. stock. As of the latest transaction made, American Portfolios Advisors holds 215 shares of CBIO stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
215Holding current value
$0% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CBIO
# of Institutions
1Shares Held
215Call Options Held
0Put Options Held
0About CATALYST BIOSCIENCES, INC.
- Ticker CBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 31,477,100
- Description
- Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...